Armistice Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-271,241
Closed -$26.1M 391
2025
Q4
$26.1M Buy
271,241
+5,984
+2% +$581K 0.31% 51
2025
Q3
$25.3M Buy
265,257
+1,257
+0.5% +$116K 0.37% 42
2025
Q2
$23M Sell
264,000
-277,237
-51% -$23.5M 0.4% 39
2025
Q1
$48.6M Sell
541,237
-208,927
-28% -$18.7M 0.73% 26
2024
Q4
$59.9M Buy
750,164
+114,236
+18% +$9.89M 0.82% 26
2024
Q3
$57.3M Sell
635,928
-188,583
-23% -$15.9M 0.92% 20
2024
Q2
$64.9M Buy
824,511
+192,152
+30% +$15.8M 0.82% 14
2024
Q1
$55.1M Buy
632,359
+24,359
+4% +$2.08M 0.73% 16
2023
Q4
$50.1M Sell
608,000
-63,407
-9% -$4.83M 0.68% 28
2023
Q3
$52.6M Sell
671,407
-84,593
-11% -$7.08M 0.81% 24
2023
Q2
$66.6M Buy
756,000
+78,000
+12% +$6.72M 0.96% 20
2023
Q1
$54.7M Buy
678,000
+6,000
+0.9% +$489K 0.79% 29
2022
Q4
$52.2M Sell
672,000
-52,000
-7% -$4.21M 0.91% 29
2022
Q3
$58.5M Sell
724,000
-76,000
-10% -$6.83M 1.01% 24
2022
Q2
$71.8K Buy
800,000
+332,000
+71% +$33.6M 1.25% 17
2022
Q1
$51.9M Sell
468,000
-244,000
-34% -$25.8M 1% 30
2021
Q4
$73.7M Buy
712,000
+262,000
+58% +$30.3M 1.21% 18
2021
Q3
$56.4M Sell
450,000
-66,000
-13% -$8.54M 0.96% 22
2021
Q2
$64.1M Sell
516,000
-20,000
-4% -$2.51M 1.15% 19
2021
Q1
$63.3M Buy
536,000
+280,000
+109% +$32.8M 1.45% 17
2020
Q4
$30M Sell
256,000
-172,000
-40% -$18.9M 1.02% 33
2020
Q3
$44.5M Sell
428,000
-164,000
-28% -$16.5M 1.61% 15
2020
Q2
$54.3M Buy
+592,000
New +$56.8M 2.38% 10

Other funds holding MDT

Armistice Capital's MDT Position: Q1 2026 in Review

Armistice Capital sold out of Medtronic (MDT) in Q1 2026, closing a stake of 271,241 shares — an estimated $26.1M sold.

Armistice Capital first reported a position in MDT in Q2 2020 and held it in 23 quarters. The position peaked at $73.7M in Q4 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Armistice Capital reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Armistice Capital sold 271,241 Medtronic shares in Q1 2026, an estimated $26.1M.
  • Armistice Capital first reported a position in Medtronic in Q2 2020 and held it in 23 quarters.
  • Armistice Capital's Medtronic position peaked at $73.7M in Q4 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.